Virios Therapeutics (VIRI) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts VIRI Hot Sheet
Join SI Premium – FREE
Virios Therapeutics (NASDAQ: VIRI) reported Q4 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- CVG to join Russell 2000 and Russell 3000 indexes June 26
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
